Get access

Recombinant proteins to induce pluripotent stem cells: Promises for a safer and thriving step toward clinical trials

Authors

  • Julien Vezoli PhD

    Corresponding author
    1. Stem-Cell and Brain Research Institute, INSERM U846, University of Lyon, Lyon 1, UMR-S 846, France
    2. Ernst Strüngmann Institute in Cooperation with Max Planck Society, Frankfurt, Germany
    • Stem-Cell and Brain Research Institute, INSERM U846, University of Lyon, Lyon 1, UMR-S 846, 69003 Lyon, France
    Search for more papers by this author

  • Relevant conflicts of interest/financial disclosures: Nothing to report.

No abstract is available for this article.

Ancillary